LAIX INC - ADR (LAIX)

ADR

3.1  -0.33 (-9.62%)

Fundamental Rating

2

LAIX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 66 industry peers in the Diversified Consumer Services industry. The financial health of LAIX is average, but there are quite some concerns on its profitability. LAIX is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

LAIX had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -26.97%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -10.58%
PM (TTM) -9.27%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, LAIX has more shares outstanding
LAIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

LAIX has an Altman-Z score of -9.28. This is a bad value and indicates that LAIX is not financially healthy and even has some risk of bankruptcy.
LAIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.28
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

LAIX has a Current Ratio of 0.20. This is a bad value and indicates that LAIX is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.20 indicates that LAIX may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.21% over the past year.
LAIX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.96%.
Measured over the past years, LAIX shows a very strong growth in Revenue. The Revenue has been growing by 198.20% on average per year.
EPS 1Y (TTM)114.21%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q121.97%
Revenue 1Y (TTM)-13.96%
Revenue growth 3Y80.42%
Revenue growth 5Y198.2%
Revenue growth Q2Q-33.38%

3.2 Future

The Earnings Per Share is expected to grow by 14.84% on average over the next years. This is quite good.
LAIX is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -13.75% yearly.
EPS Next Y99.57%
EPS Next 2Y41.34%
EPS Next 3Y25.97%
EPS Next 5Y14.84%
Revenue Next Year-27.88%
Revenue Next 2Y-22.1%
Revenue Next 3Y-16.08%
Revenue Next 5Y-13.75%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LAIX. In the last year negative earnings were reported.
Also next year LAIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -13.56

4.3 Compensation for Growth

LAIX's earnings are expected to grow with 25.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.34%
EPS Next 3Y25.97%

0

5. Dividend

5.1 Amount

No dividends for LAIX!.
Industry RankSector Rank
Dividend Yield N/A

LAIX INC - ADR

NYSE:LAIX (4/7/2022, 7:04:00 PM)

3.1

-0.33 (-9.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap154.68M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.97%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -10.58%
PM (TTM) -9.27%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)114.21%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y99.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.96%
Revenue growth 3Y80.42%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y